Crystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl group
about
Molecular analysis of thymopentin binding to HLA-DR moleculesAn N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivoTypes of inter-atomic interactions at the MHC-peptide interface: identifying commonality from accumulated dataClass I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contactsIdentification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A virusesInflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complexPeptide modulation of class I major histocompatibility complex protein molecular flexibility and the implications for immune recognition.Major histocompatibility complex class I molecules bind natural peptide ligands lacking the amino-terminal binding residue in vivo.Predicting peptide binding affinities to MHC molecules using a modified semi-empirical scoring function.Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes.Tapasin and other chaperones: models of the MHC class I loading complex.Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine designStructural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.Water dynamics at the binding interface of four different HLA-A2-peptide complexes.Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue.Strategic mutations in the class I major histocompatibility complex HLA-A2 independently affect both peptide binding and T cell receptor recognition.Examination of possible structural constraints of MHC-binding peptides by assessment of their native structure within their source proteins.
P2860
Q21092228-FA1B518F-8DD8-426C-923C-5319497F6703Q24676272-1FCE5923-EB1B-4557-A509-0567B33F5D60Q24793027-5B9054C9-004D-4EC0-AA3B-FE3C523F03C2Q27631018-D80DEF15-A8F6-4E5A-ADB6-E40B9D0CFB47Q27658413-86355A58-BCB3-44AF-957F-EF37EC35D9E6Q28481493-20CDB9C9-3112-430E-ADE0-566625A25DE5Q30351955-5025C973-BA01-4BA9-8C6A-4E60031B5544Q30718387-FF5CF4AF-5C40-420D-A816-AACCB8C291B2Q34037944-2DB07BD6-E02A-45BA-9D87-827CD40A22AFQ35718060-08D4C9C5-68E8-458F-BE12-8D99C25BB769Q35922740-40C18817-33D5-4336-AC48-A37D127FBF47Q36456760-823B871E-FB57-47D3-BCC1-D79A85BD82FCQ40279655-EAC98D99-0772-492E-A65E-4F1D5CA14A65Q40321837-B8C3072F-FAE2-4B94-A091-2ABB51BCDAACQ41745329-E38612FF-DBE2-469D-8EDA-B89DE3D2A878Q44788642-5E6AAC96-0D6E-47F3-9237-224C6BCBF9ABQ44886665-066168F9-DDE5-4746-931F-268D2B0C7A79Q47617870-AD3ABBB5-BFF2-4795-86F0-812C705B527D
P2860
Crystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl group
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@ast
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@en
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@nl
type
label
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@ast
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@en
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@nl
prefLabel
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@ast
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@en
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@nl
P2093
P2860
P1433
P1476
Crystal structures of HLA-A*02 ...... substituted by a methyl group
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I
P407
P577
1998-10-01T00:00:00Z